Imugene bringing effective new treatments and options to cancer patients

Be the First to Comment Read

Imugene bringing effective new treatments and options to cancer patients

Imugene Limited (ASX:IMU) is a clinical stage immuno-oncology company involved in developing a range of new and novel immunotherapies that seek to activate a cancer patient’s immune system to detect and eliminate tumours. Over the years, it has grown tremendously to become one of the top three largest biotech companies in Australia. 

Disclaimer

Speak your Mind

Ad
kalkine logo

GET A FREE STOCK REPORT

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK